Galafold Capsule
Product Images NDC 71904-100

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Galafold (NDC 71904-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amicus Therapeutics Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Galafold 01)

Chemical structure of migalastat hydrochloride, the active ingredient in Galafold 123 mg capsules. The diagram shows the molecular arrangement including hydroxyl groups and an HCl moiety.*

FDA Label Image

Figure A (Galafold 02)

An instructional illustration showing hands holding a blister strip of Galafold (migalastat hydrochloride) capsules, demonstrating the method to push capsules out from the blister packaging. The image guides proper capsule removal from the oral dosage form packaging by Amicus Therapeutics US, LLC.*

FDA Label Image

Figure B (Galafold 03)

An instructional illustration showing a person's hands holding a product carton for Galafold capsules. The diagram highlights features including capsule appearance, safety caps, and instructions on how to open the packaging, relevant to the oral dosage form of migalastat hydrochloride, 123 mg strength by Amicus Therapeutics US, LLC.*

FDA Label Image

Figure C (Galafold 04)

An instructional diagram showing a person holding a blister card of capsules in one hand and a folded paper insert in the other. The paper insert displays text and images, likely containing usage instructions or product information for the medication.*

FDA Label Image

Figure D (Galafold 05)

Packaging blister card for Galafold 123 mg capsules by Amicus Therapeutics US, LLC, showing a 28-day oral dosing schedule with individual capsule spaces labeled by day. The card is designed to track daily capsule intake for a four-week period.*

FDA Label Image

Figure E (Galafold 06)

An instructional illustration showing a two-week (28-day) medication blister pack for oral capsules. The pack is labeled with days 1 through 28 and displays individual capsule compartments arranged in two rows, with a perforation separating the two weeks. The diagram includes hands holding the package, indicating how to open or use the blister pack over the course of a month.*

FDA Label Image

Figure F (Galafold 07)

An instructional illustration showing a hand holding a pencil marking or filling in a medication adherence or tracking calendar labeled with days (Day 1, Day 2, Day 4, Day 6, Day 8) and a space for the starting date. This likely represents tracking oral medication doses over several days.*

FDA Label Image

Figure G (Galafold 08)

An instructional diagram showing hands peeling open a blister pack with capsules inside, illustrating how to remove the capsules from the packaging. No text or branding is visible.*

FDA Label Image

Figure H (Galafold 09)

An instructional illustration depicting a hand holding an oral capsule, with the thumb and forefinger grasping the capsule as if preparing to open or consume it. The capsule appears partially open or is being manipulated.*

FDA Label Image

Carton Label (inner Sleeve) (Galafold 10)

An illustration showing a hand holding a dosage card labeled with days 2, 3, 4, 5, 6, and 7 for taking capsules. Each day is marked by a capsule-shaped outline, some filled, indicating dosing schedule or tracking for an oral capsule regimen.*

FDA Label Image

Carton Label (outer Sleeve) (Galafold 11)

An instructional diagram showing a finger pointing to a pill organizer with labeled compartments for Day 1 through Day 5, used to track daily medication doses starting on a marked day.*

FDA Label Image

Galafold 12

Blister card packaging label for Galafold (migalastat) 123 mg capsules by Amicus Therapeutics US, LLC. The label shows 14 capsules per card, divided into two sections of 14 capsules each, for a total of 28 doses. Each dose is marked by day, with perforated circles to punch out days the medication is not taken. The card includes instructions for alternate day dosing and storage temperature recommendations.*

FDA Label Image

Galafold 13

Packaging label for Galafold 123 mg capsules (migalastat) by Amicus Therapeutics US, LLC. The label highlights 14 capsules per pack and includes instructions for use, capsule removal, storage conditions, and a dosage schedule illustration. The NDC 71904-100-01 and a barcode are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.